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Objective: The current guidelines for the diagnosis of heart failure (HF) are based on studies 
of hospital-based patients. The aim of this study is to describe the symptoms, clinical signs, and 
diagnostic procedures confirming the diagnosis of HF in primary health care.
Materials/subjects and methods: Data were prospectively collected during a 2-year period 
by a nationwide network of sentinel practices. All adult patients without known HF, for which 
the diagnosis of HF was clinically suspected for the first time, were registered. When diagnosed, 
HF was confirmed after 1 month.
Results: 754 patients with a suspicion of HF were recorded. The diagnosis of HF was confirmed 
for 74% of the patients. The average age of the patients with confirmed HF was 77.7 years, 
and for those without HF 75.6 years (P = 0.018). From a logistic regression, breathlessness on 
exercise (P , 0.001), limitations of physical activity (P = 0.003), and orthopnea (P = 0.040) 
were the symptoms most associated with HF. The clinical signs most associated with HF, 
were pulmonary rales (P , 0.001), peripheral edema (P , 0.001), and raised jugular venous 
pressure (P = 0.039). An electrocardiogram was performed in 75% of the cases, blood analyses 
in 68%, echocardiogram in 63%, chest X-ray in 61%, and determination of natriuretic peptides 
in 11% of the cases.
Conclusion: Many clinical signs may occur in patients with HF. However, the occurrence of 
peripheral edema, breathlessness on exercise, or pulmonary rales, are highly suggestive for HF 
when diagnosed in primary health care, as is the case in hospital-admitted patients. The diagnosis 
of HF was often left unconfirmed by an echocardiogram and/or an electrocardiogram.
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Introduction
Heart failure (HF) is a common diagnosis in primary health care. It is becoming 
one of the main causes of morbidity and mortality in the Western world.1 Diagnosis 
of HF is related to a poor prognosis. In 1933, Sir Thomas Lewis emphasized in his 
textbook “Diseases of the Heart” that “the very essence of cardiovascular medicine 
is the recognition of early heart failure.”2
The short- and long-term outcome for patients with HF is considered worse than 
for most malignant diseases. The risk of mortality increases more than three-fold 
with HF.3 With the aid of the newest drugs and devices, the chances of survival for 
patients with HF have improved. However, the diagnosis of HF remains problematic 
in primary health care. Many definitions of HF have been used over the last 50 years.4 
Most definitions emphasized the combination of symptoms of HF and clinical signs 
of fluid retention.5 According to the guidelines of the European Society of Cardiology 
Dovepress




open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/VHRM.S24476Vascular Health and Risk Management 2011:7
(ESC), HF is defined as a clinical syndrome, in which patients 
have symptoms, as well as clinical signs, typical of HF. The 
need for objective evidence of a structural or functional 
abnormality of the heart at rest is also incorporated in this 
definition.6
Almost all guidelines are based on evidence resulting 
from epidemiological and clinical studies, performed on 
hospital-based patients.4–6 Very little reliable data exists about 
the diagnostic procedures for patients who present with HF in 
primary health care. Because of the differences in the clinical 
presentation and the severity of HF in primary health care 
patients, as compared to hospital-based patients, it is likely 
that symptoms and clinical signs leading to the diagnosis of 
HF may differ between these patient groups.
The aim of this study is to describe the symptoms, clinical 
signs, and diagnostic procedures confirming the diagnosis of 
HF in primary health care.
Materials and methods
The Belgian network of sentinel practices
The data for this study were collected by the Belgian network 
of sentinel practices. This network serves as a reliable source 
on the surveillance of morbidity in Belgium, and has been 
operating with similar methods since 1979.7–9 The network 
has already been tested and proven effective as a surveil-
lance system.9–11 Similar networks are currently applied in 
many other countries.12,13 The sentinel practices are distrib-
uted evenly over the Belgian territory by means of a cluster 
analysis, based on epidemiological criteria.7,8 The network 
of sentinel practices consists of family physicians who, 
with respect to age and gender, are representative of family 
physicians in Belgium. The yearly adult sentinel population 
during the registration period was estimated to be 143,705 
or almost 1.8% of the Belgian adult population.
Registration by the Belgian Network of Sentinel General 
Practices has been approved by an ethical committee. There 
was no specific ethical approval necessary for the present 
study, because it concerned a registration of the usual care 
provided without interventions.
Case ascertainment
The data were collected during a 2-year period from 
178 sentinel practices, who participated in the registrations 
at least 26 weeks a year. The participating family physicians 
were asked to register all their adult patients without known 
HF, for whom a diagnosis of HF was suspected for the 
first time. The observations were initially registered on 
the weekly registration form, together with other themes in 
the observation program. The possibility of HF was based 
on the patient’s symptoms and clinical signs.
For every recorded patient, the participating family 
physician was sent an additional in-depth questionnaire 
1 month after the initial registration. The physicians then 
provided additional or more detailed information on 
diagnostic criteria and complementary examinations, on 
which the final diagnosis was based. Examples of additional 
or more detailed information are: clinical improvement with 
proper therapy, specialist consultation or objective evidence 
of cardiac anomalies on echocardiography, or chest X-ray.
Data management and statistical analysis
Data were entered weekly at the Scientific Institute of Public 
Health. The data analyses for this study were performed using 
SPSS (v 17.0; SPSS Inc, Chicago, IL). Univariate association 
between diagnosis of HF and symptoms/clinical signs was 
tested by means of chi square tests. Fisher’s exact test was 
used when less than ten observations were concerned. 
Multivariate analyses were performed with backward 
stepwise logistic regression, to look at the association 
between the diagnosis of HF and symptoms/clinical signs. 
Also the sensitivity, specificity, positive predictive value 
(PPV), and the negative predictive value (NPV) of different 
symptoms and clinical signs were calculated.
Results
Characteristics of the population
In total, 754 patients were suspected to have newly diagnosed 
HF during the 2 years of the registration. The diagnosis of 
HF was confirmed for 557 patients (or 74% of all recorded 
patients) after 1 month. In total, 56% of the patients with 
confirmed HF were female and 44% were male. The patients 
without HF were 51% male and 49% were female. The 
average age of the patients with confirmed HF was 77.7 years 
(SD = 10.3; range 26–101) and for those without HF 
75.6 years (SD = 11.2; range 30–100; P = 0.018).
Symptoms and clinical signs
The most common symptoms among the patients with HF 
were breathlessness on exercise (67%) and limitations of 
physical activity (60%). All symptoms occurred signifi-
cantly more often among patients with HF, as compared to 
those without HF (Table 1). All symptoms had fair or good 
specificity, but only two had good sensitivity. The most 
common symptoms among those without HF (breathlessness 
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on exercise [38%], limitation of physical activity [37%], 
and fatigue [28%]) also had fair or good specificity and 
sensitivity for HF.
During physical examination of the patients with HF, 
peripheral edema was observed in 68%, and pulmonary rales 
in 62% of the cases. All clinical signs occurred significantly 
more often among patients with HF, as compared to those 
without HF (Table 1). All clinical signs had fair or good 
specificity but only two had good sensitivity. The most 
common clinical signs among those without HF (peripheral 
edema [36%] and pulmonary rales [33%]) also had good 
specificity and sensitivity for HF.
For the patients with HF, an electrocardiogram was 
  performed in 75%, blood analyses in 68%, echocardiogram 
in 63%, chest X-ray in 61%, and determination of natriuretic 
peptides in 11% of the cases. All investigations were 
  performed significantly more often among patients with HF 
as compared to those without diagnosed HF.
To determine the symptoms and clinical signs with the 
highest association with the diagnosis of HF, we built a 
model on the basis of patient characteristics, using backward 
stepwise logistic regression, with diagnosis of HF after 
1 month as a dependent variable (Table 2). Breathlessness 
on exercise (P , 0.001), pulmonary rales (P , 0.001), 
peripheral edema (P , 0.001), limitation of physical activity 
(P = 0.003), raised jugular venous pressure (P = 0.039), and 
orthopnea (P = 0.040) had the highest association with the 
diagnosis of HF.
Finally, the sensitivity, specificity, PPV, and NPV 
were calculated for all symptoms and clinical signs 
Table 1 Symptoms and clinical signs for patients with and without heart failure
Heart failure 
(n = 557) 
n (%)
No heart failure 
(n = 197) 
n (%)
P value Sens Spec PPV NPV
nocturnal dyspnea 143 (26) 22 (11) ,0.001 0.26 0.89 0.87 0.30
Orthopnea 258 (46) 43 (22) ,0.001 0.46 0.78 0.86 0.34
Limitations of physical activity 334 (60) 72 (37) ,0.001 0.60 0.64 0.82 0.36
Breathlessness on exercise 372 (67) 74 (38) ,0.001 0.67 0.62 0.83 0.40
Fatigue 258 (46) 55 (28) ,0.001 0.46 0.72 0.82 0.32
Other symptoms 65 (12) 25 (13) 0.70 0.12 0.87 0.72 0.26
Third heart sound 58 (10) 6 (3) 0.001 0.10 0.97 0.91 0.28
Cardiac murmurs 123 (22) 25 (13) 0.004 0.22 0.87 0.83 0.28
Pleural effusion 128 (23) 22 (11) ,0.001 0.23 0.89 0.85 0.29
Pulmonary rales 344 (62) 64 (33) ,0.001 0.62 0.68 0.84 0.38
Raised jugular venous pressure 145 (26) 19 (10) ,0.001 0.26 0.90 0.88 0.30
Hepatomegaly 87 (16) 8 (4) ,0.001 0.16 0.96 0.92 0.29
Peripheral edema 381 (68) 70 (36) ,0.001 0.68 0.65 0.85 0.42
Other clinical signs 89 (16) 20 (10) 0.046 0.16 0.90 0.82 0.27
Abbreviations: PPV, positive predictive value; nPV, negative predictive value.
Table 2 Logistic regression stepwise backwards (last step) with the diagnosis of heart failure as independent variable and the different 






t P value 95% confidence interval for B
B Standard error Lower bound Upper bound
Orthopnea 0.07 0.03 0.08 2.05 0.040 0.01 0.13
Limitations of physical activity 0.09 0.03 0.10 3.02 0.003 0.03 0.15
Breathlessness on exercise 0.12 0.03 0.14 3.90 ,0.001 0.06 0.18
Third heart sound 0.10 0.05 0.06 1.94 0.053 -0.01 0.20
Pulmonary rales 0.14 0.03 0.15 4.26 ,0.001 0.07 0.20
Raised jugular venous pressure 0.08 0.04 0.07 2.07 0.039 0.01 0.15
Peripheral edema 0.20 0.03 0.22 6.54 ,0.001 0.14 0.26
Others clinical signs 0.11 0.04 0.09 2.99 ,0.001 0.03 0.19
Notes: Logistic regression within the first step gender, age, nocturnal dyspnea, orthopnea, limitations of physical activity, breathlessness on exercise, fatigue, other symptoms, 
third heart sound, cardiac murmurs, pleural effusion, pulmonary rales, raised jugular venous pressure, hepatomegaly, peripheral edema, and other clinical signs.
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(Table 1). Peripheral edema, breathlessness on exercise, and 
pulmonary rales had fair sensitivity and specificity for the 
prediction of HF.
Many models of combinations of symptoms and clinical 
signs were tested for their sensitivity and specificity. 
The combination of peripheral edema and breathlessness 
on exercise and pulmonary rales had good specificity 
(spec = 0.89) to detect HF, but low sensitivity (sens = 0.31). 
The occurrence of peripheral edema or breathlessness 
on exercise or pulmonary rales had good sensitivity 
(sens = 0.96) but moderate specificity (spec = 0.41) for the 
prediction of HF.
Diagnosis for patients without heart 
failure
For 26% of the patients, the diagnosis of HF was not 
confirmed after 1 month. Airway infections or obstructive 
airway diseases were the most common diagnosis in this 
group (25%). Other common diagnoses for patients without 
HF were peripheral edema caused by venous insufficiency 
(21%), malaise (15%), ischemic cardiac disease or 
arrhythmia (9%), non-cardiac chest pain (6%), and various 
other diseases (24%).
Discussion
Peripheral edema, breathlessness on exercise, and pulmonary 
rales had the best sensitivity and specificity to detect HF. 
One in four patients with a suspicion of HF did not receive 
an electrocardiogram and an echocardiogram was performed 
on only two in three patients. All diagnostic procedures were 
performed significantly more often among patients for whom 
the diagnosis of HF was made, as compared to those for 
whom the diagnosis of HF was not made. It is possible that 
in the group without HF, more diagnoses of HF could have 
been made if more diagnostic tests had been performed.
Belgian network of Sentinel general 
Practitioners
One of the most important characteristics of the Belgian 
Network of Sentinel General Practitioners (GPs) is its 
stability in terms of participating GPs. The GPs are highly 
motivated to monitor various diseases over a period of several 
years. They have not been selected on the basis of a specific 
interest in the diagnosis or treatment of HF.
Detailed information concerning provided care is not 
always available from medical records in Belgium. Therefore, 
direct registration by GPs has important added value. Also, 
the network offers the opportunity to monitor a representative 
sample of the entire population. For several conditions, 
such as suicide and the incidence and mortality of stroke 
and cancer, comparisons with the data from the National 
Institute for Statistics have shown that the Belgian Network 
of Sentinel General Practitioners provides information that 
is representative for the entire Belgian population.9,14,15 The 
choice of GPs is clinically relevant as they represent the 
pivotal figures involved in the early diagnosis in Western 
societies and the subsequent follow-up of HF patients.
In many epidemiological studies, data collection is retro-
spective. For example, HF was identified in the Framingham 
Heart Study by examining individuals within a cohort and 
at certain intervals.16 However, in the Helsinki Aging Study 
and in some other more recent registrations, data were 
accessed by population-based surveillance systems in which 
individuals developing HF were prospectively included.17–19 
Our registration also uses a prospective registration of HF, 
which has the advantage that incident cases may be fully 
characterized at the time of the diagnosis.
The retrospective recall bias found in other retrospective 
research designs, will be limited in the registrations by our 
network, because the weekly registrations leave little time 
between the onset of HF and registration.20,21
Unfortunately, the surveillance system by the Sentinel 
Network also has some weaknesses. Time-consuming 
questions were avoided to keep the registration form simple. 
For this type of registration, in-depth research of more 
complicated aspects of disease and health conditions is not 
possible.22
Diagnosis of heart failure
Currently, no universal definition of HF exists. This lack of 
uniform definition hampers the comparison of symptoms and 
signs for HF in different studies. Most patients with HF seek 
medical attention with nonspecific symptoms and clinical 
signs. Therefore, the early diagnosis of HF requires good 
medical history and careful physical examination, including 
observation, palpation, and auscultation.23 Tiredness, fatigue, 
and breathlessness are very common complaints. Assessing 
these symptoms among the elderly requires training and 
experience.24
From our logistic regression analyses, the presence of 
pulmonary rales, peripheral edema, and raised jugular venous 
pressure are highly associated with the diagnosis of HF. The 
symptoms as well as the clinical signs of HF are difficult to 
interpret. Almost all symptoms and clinical signs have good 
specificity but sensitivity is only good for breathlessness on 
exercise, pulmonary rales, peripheral edema, and limitation 
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of physical activity. The key symptoms such as tiredness, 
fatigue, and breathlessness are very nonspecific among 
elderly and obese patients. In these cases, the diagnosis of 
HF needs to be confirmed by more objective tests with an 
assessment of cardiac function.
The ESC recommends a number of investigations 
to confirm the diagnosis of HF.6 Patients for whom HF 
is suspected, should not only have a thorough clinical 
examination but also an electrocardiogram, a chest X-ray, 
and an echocardiogram. These diagnostic procedures were 
not always performed in our registration. The participating 
family physicians were free to perform these procedures, if 
they thought they might contribute to the diagnosis.
A strength of our study is that the diagnosis of HF was 
confirmed after 1 month, giving the family physicians the 
opportunity for further investigations, and excluding most of 
the inaccurate diagnoses. In our study, the diagnosis of HF 
was confirmed after 1 month for 74% of all recorded patients. 
This is remarkably better than a study from the UK, where 
for 70% of patients with a primary care diagnosis of HF, 
the diagnosis was not confirmed.25 However, in this kind of 
study, the proportion of patients with confirmed HF strongly 
depends on the study sample.
On the other hand, in primary health care, most of the 
diagnostic procedures are not very specific for HF. Chest 
X-ray permits differential diagnoses with other causes of 
dyspnea, but has little power to exclude HF. Echocardiography 
provides insight into the function of several parts of the heart, 
but for many years there was doubt about the usefulness of 
echocardiography to confirm or exclude HF.26 Nowadays, 
more evidence exists regarding the prognostic importance of 
echocardiography in patients with “borderline” ventricular 
function.27 A normal concentration of natriuretic peptides 
makes the diagnosis of HF unlikely, but increased levels have 
only little predictive value for HF.
Conclusion
From this 2-year prospective registration in primary health 
care, we conclude that many symptoms and clinical signs may 
appear among patients with HF. Similar to the results of the 
hospital-based studies, the study shows that peripheral edema, 
breathlessness on exercise, and pulmonary rales are the most 
reliable symptoms and clinical signs for the diagnosis of HF 
in primary health care. To determine these specific diagnostic 
characteristics, all patients in primary health care with a 
suspicion of HF need a thorough medical history taken, 
and careful physical examination including observation, 
palpation, and auscultation. The occurrence of peripheral 
edema, breathlessness on exercise, or pulmonary rales in 
primary health care is highly suggestive for HF and needs 
to be evaluated by specific diagnostic procedures evaluating 
cardiac function. Too many patients with suspected HF don’t 
receive an electrocardiogram or an echocardiogram.
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